EUVIMEDEUVIMED entdecken
Open Access

Accelerating Medicinal Chemistry: A C(sp 3 )‐Rich Fragment Toolbox for Redox‐Neutral Cross‐Coupling

Jet Tsien iD, Áron Péter iD, Xin Zeng, Shuanghu Wang, Baiyang Jiang, Megan A Emmanuel, Martins S Oderinde, Philippe N Bolduc, Michael C Nicastri, Shalini Dey, Michael R Collins, Johnny W Lee und 8 weitere

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202517207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Jet Tsien und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA. Hauptthemen laut MEDLINE: Chemistry, Pharmaceutical. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, MSCA-GF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hit‐to‐lead phase of drug discovery is frequently bottlenecked by the time‐consuming, iterative synthesis of analogs, especially when incorporating small C(sp 3 )‐rich fragments such as methyl, cyclopropyl, or oxetanyl groups—moieties known to improve drug solubility, bioactivity, and metabolic stability. Conventional approaches like Suzuki or Negishi couplings make use of unstable reagents, high costs, and harsh reaction conditions, while many modern radical‐based methods rely on exogenous redox agents or costly metal catalysts. To overcome these limitations, a toolbox of 15 sulfonyl hydrazide reagents is disclosed to facilitate redox‐neutral, nickel‐catalyzed radical cross‐coupling of 14 distinct small fragments onto (hetero)arenes under mild conditions. These crystalline, bench‐stable reagents are straightforward to synthesize from accessible precursors and require no additional oxidants, reductants, or precious metals, offering a modular and operationally simple platform. Demonstrated across a diverse set of over 60 (hetero)aryl halides, the method exhibits exceptional substrate scope and functional group tolerance, accommodating complex, medicinally relevant scaffolds. Comparative studies with existing techniques underscore its advantages, including a 51% yield for trideuteromethylation of a MET kinase inhibitor precursor (versus a precedented 14% via Kumada coupling) and a streamlined one‐step cyclobutylation of an NLRP3 inhibitor intermediate at 41% yield (versus a known < 5% over a four‐step sequence).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemistry, PharmaceuticalOxidation-ReductionCatalysisNickelMolecular Structure

Stichwörter der Autor:innen

Heteroaryl Halide FunctionalizationNickel‐catalysisRedox‐neutral Radical CouplingSmall‐fragment Coupling

Substanzen

Nickel

Autor:innen und Institutionen

  • Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA.
  • Chemical Process Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ, 08901, USA.
  • Small Molecule Drug Discovery, Bristol Myers Squibb Research & Early Development, Route 206 & Province Line Road, Princeton, NJ, 08543, USA.
  • Biogen Inc., 225 Binney Street, Cambridge, MA, 02142, USA.
  • Department of Chemistry, La Jolla Laboratories, Pfizer Inc., 10770 Science Center Drive, San Diego, CA, 92121, USA.
  • Chemical Research and Development, Pfizer Research and Development, Eastern Point Road, Groton, Connecticut, 06340, USA.

ORCID-Profile: Jet Tsien, Áron Péter, Phil S Baran

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • MSCA-GF
  • National Science Foundation

Zitieren

APA

Tsien, J., Péter, Á., Zeng, X., Wang, S., Jiang, B., Emmanuel, M. A., Oderinde, M. S., Bolduc, P. N., Nicastri, M. C., Dey, S., Collins, M. R., Lee, J. W., Bravo, M., Richardson, P. F., Sach, N. W., Bernier, L., Palkowitz, M. D., Qiao, J. X., Kawamata, Y., & Baran, P. S. (2025). Accelerating Medicinal Chemistry: A C(sp 3 )‐Rich Fragment Toolbox for Redox‐Neutral Cross‐Coupling. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202517207

Vancouver

Tsien J, Péter Á, Zeng X, Wang S, Jiang B, Emmanuel MA, et al. Accelerating Medicinal Chemistry: A C(sp 3 )‐Rich Fragment Toolbox for Redox‐Neutral Cross‐Coupling. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202517207

BibTeX
@article{Tsien2025,
  author = {Tsien, Jet and Péter, Áron and Zeng, Xin and Wang, Shuanghu and Jiang, Baiyang and Emmanuel, Megan A and Oderinde, Martins S and Bolduc, Philippe N and Nicastri, Michael C and Dey, Shalini and Collins, Michael R and Lee, Johnny W and Bravo, Martin and Richardson, Paul F and Sach, Neal W and Bernier, Louise and Palkowitz, Maximilian D and Qiao, Jennifer X and Kawamata, Yu and Baran, Phil S},
  title = {Accelerating Medicinal Chemistry: A C(sp 3 )‐Rich Fragment Toolbox for Redox‐Neutral Cross‐Coupling},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202517207}
}
Kostenlos starten →